Hepatitis C market competition arrives for 2015 | Formulary Journal

January 7, 2015 2:26 AM

14 0

There is plenty of activity already in the hepatitis C market as competition has arrived for 2015, including CVS Health versus Express Scripts and Gilead Sciences versus AbbVie, over FDA-approved hepatitis C treatments. This will have implications for retail prescriptions as well as continuity-of-care programs within non-Medicare accountable care organizations (ACOs) and health systems.

The market leaders in the pharmacy benefit manager (PBM) and pharmaceutical markets have staked their positions and are ready to battle in 2015, even as other firms are poised to enter the hepatitis C market later.

Read more

To category page